Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2021-08-25
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care
NCT02804438
Outcome pRognostication of Acute Brain Injury With the NeuroloGical Pupil indEx
NCT04490005
Interrater Reliability of Subjective Pupillary Assessments
NCT02296606
The Neurological Pupil Index (NPi) on Intensive Care Unit (ICU) Trial
NCT01920347
A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity
NCT06144151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If there is a significant difference between readings from the NPi-200 and the NPi-300, we will repeat the bilateral assessment in the following hour and the regularly scheduled time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Patients with risk of cerebral edema.
NPi-200 and NPi-300 pupillometers
Device which measures PLR.
Healthy Control
Staff/Faculty who interact with patients at the enrolling site.
NPi-200 and NPi-300 pupillometers
Device which measures PLR.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NPi-200 and NPi-300 pupillometers
Device which measures PLR.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Staff in the enrolling site
Exclusion Criteria
* None
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NeurOptics Inc.
INDUSTRY
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DaiWai Olson
Director of Neuroscience Nursing Research Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DaiWai M Olson, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Texas Southwestern Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clements University Hospital
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU-2021-0693
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.